CompoAtlas

Juice PLUS ® + OGU MAISĪJUMS+ ( 2019. )

Food supplement registered in Latvia

Register snapshot dated 2 May 2025. It does not establish the current status of the product.

Number published by PVD
0000685/2019
Type
Food supplement
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
The Juice Plus + Company GmbH
Manufacturer
name not reproduced (no recognised company form)
Origin
Vācija
Register snapshot
2 May 2025
Recommended daily intake (Latvian text)
2 kapsulas dienā
Published pack size
kapsulas pa 0.8 g
Published packaging
120 kapsulas

This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

The foreign register category does not determine the regulatory category of the product in France.

Published composition

Published namePublished text and quantityRecognised ingredientRole or context
E VITAMĪNSvitamins ; E VITAMĪNS ; 9.0 ; mg α-TEVitamine EVitamin or mineral
C VITAMĪNSvitamins ; C VITAMĪNS ; 29.0 ; mgVitamine CVitamin or mineral
Vīnogu augļu pulverisplants ; Vīnogu augļu pulveris ; Vitis labrusca ; 237.0 ; mgvitis labruscaPlant
Granātābolu augļu pulverisplants ; Granātābolu augļu pulveris ; Punica granatum ; 124.0 ; mgpunica granatumPlant
Augsto krūmmelleņu augļu pulverisplants ; Augsto krūmmelleņu augļu pulveris ; Vaccinium corymbosym ; 100.0 ; mgNot recognisedRole not identified
Lielogu dzērveņu pulverisplants ; Lielogu dzērveņu pulveris ; Vaccinium macrocarpon ; 63.0 ; mgvaccinium macrocarponPlant
Kazeņu augļu pulverisplants ; Kazeņu augļu pulveris ; Rubus fruticosus ; 50.0 ; mgrubus fruticosusPlant
Melleņu augļu pulverisplants ; Melleņu augļu pulveris ; Vaccinium myrtillus ; 28.0 ; mgvaccinium myrtillusPlant
Meža aveņu augļu pulverisplants ; Meža aveņu augļu pulveris ; Rubus idaeus ; 23.0 ; mgrubus idaeusPlant
Melnā plūškoka augļu pulverisplants ; Melnā plūškoka augļu pulveris ; Sambucus nigra L. ; 15.0 ; mgsambucus nigraPlant
Upeņu augļu pulverisplants ; Upeņu augļu pulveris ; Ribes nigrum ; 12.0 ; mgribes nigrumPlant
Kakao sēklu pulverisplants ; Kakao sēklu pulveris ; Theobroma cacao ; 246.0 ; mgtheobroma cacaoPlant
Zaļās tējas lapu ekstrakts ( DER 6:1)plants ; Zaļās tējas lapu ekstrakts ( DER 6:1) ; Camellia sinensis ; 79.0 ; mgcamellia sinensisPlant
Ingvera saknes pulverisplants ; Ingvera saknes pulveris ; Zingiber officinale ; 57.0 ; mgzingiber officinalePlant
Artišoka lapu ekstrakts (DER 15 -30:1)plants ; Artišoka lapu ekstrakts (DER 15 -30:1) ; Cynara scolimus L. ; 30.0 ; mgNot recognisedRole not identified
Vīnogu sēklu ekstrakts (DER 10-15:1)plants ; Vīnogu sēklu ekstrakts (DER 10-15:1) ; Vitis vinifera ; 25.0 ; mgvitis viniferaPlant
Apelsīnu augļu ekstrakts (DER 60 -80:1)plants ; Apelsīnu augļu ekstrakts (DER 60 -80:1) ; Citrus sinensis ; 5.0 ; mgcitrus sinensisPlant
Silīcija dioksīds (E 551)otherIngredients ; Silīcija dioksīds (E 551)Not recognisedRole not identified
Taukskābju magnija sāļi (E 470b)otherIngredients ; Taukskābju magnija sāļi (E 470b)Not recognisedRole not identified
Pullulāns (E1204)otherIngredients ; Pullulāns (E1204)Not recognisedRole not identified

Quantities are reproduced as published. The export does not specify their basis: the recommended daily intake cannot be used to calculate a daily dose. No daily dose is estimated. Latvian names are retained without translation.

Manufacturer countries

Šveice

French and European references for recognised ingredients

Unrecognised ingredients are not assessed. The absence of a signal does not establish product compliance.

Official source

View the official register

Official PVD export

Internet Archive copy dated 3 May 2025

PVD, food supplement register, CC0 1.0. Quantities and the date of each snapshot are retained as published.

CC0 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Granātābolu augļu pulveris
    Read the warning, when it applies and the studies cited
  • Lielogu dzērveņu pulveris
    Read the warning, when it applies and the studies cited

    CRANBERRY - VACCINIUM MACROCARPON

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: (Recurrent) urinary tract infection.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 27 March 2026

    DRIED CRANBERRY JUICE

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a history of kidney stones (Gettman et al. 2005; Terris et al. 2001).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Brinker 2010; Aston et al. 2006; Rindone and Murphy 2005; Grant 2004).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: (Recurrent) urinary tract infection.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 27 March 2026

  • Melleņu augļu pulveris
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

  • Melnā plūškoka augļu pulveris
    Read the warning, when it applies and the studies cited

    ELDER – SAMBUCUS

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Diaphoretic; Symptoms of colds, flus; Sinusitis, hay-fever; Joint pain.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occur (Forster-Waldl et al. 2003).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: All products except those making a diuretic claim.

    When using this product diuretic effect may occur (Bradley 1992; Winston and Kuhn 2008; Barnes et al. 2007; Hoffman 2003).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 19 December 2025

  • Ingvera saknes pulveris
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line